About this episode
As concerns mount regarding the health of the private credit ecosystem, Oaktree Capital Management co-chairman Howard Marks offers perspective–and some investing advice–when it comes to private lending. Former FDA Commissioner Dr. Scott Gottlieb discusses Eli Lilly’s deal to expand its cancer treatment pipeline as well as President Trump’s executive order on therapeutic psychedelics. Plus, Kevin Warsh’s Fed Chair nomination hearing is this week, and Anthropic’s Mythos is at work within the NSA, despite being blacklisted by the US government.
Steve Liesman 14:36
Howard Marks 23:54
Dr. Scott Gottlieb 41:27
In this episode:
Steve Liesman, @steveliesman
Andrew Ross Sorkin, @andrewrsorkin
Becky Quick, @BeckyQuick
Joe Kernen, @JoeSquawk
Katie Kramer,
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time Squawk Pod publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Squawk Pod
25 Years Later 9/11/26
Squawk Pod
AI Alarms, Canada’s Opposition, The GOP Convention 9/10/26
Squawk Pod
Microsoft’s Brad Smith & Utah Gov. Cox: AI, Teaching, & Peace 9/9/26
Squawk Pod
GLPs & Fraud with Dr. Oz & Kevin O’Leary’s $11m Baseball Card 9/8/26
Squawk Pod